Pall Biotech designates newly expanded Belgian facility as strategic hub

Pall Biotech has expanded its Hoegaarden facility in Belgium, designating it as a new strategic hub for research & development (R&D), manufacturing and customer support.

The expansion includes 2,000 m² of new office space in addition to new R&D customer demonstration labs and manufacturing space.

“The expanded Hoegaarden site has it all: offices, labs, and manufacturing space for development and optimization of customer processes. With this site, we will be better equipped to provide whole service to customers in the area, while supporting the local economy,” said Mario Philips, vice president and general manager of Pall Biotech. “In this new space, we have consolidated three Pall Belgian offices as one, which is why we have designated Hoegaarden as a hub of strategic importance for our future growth.”

The expansion took eight months to complete and has combined three Belgian locations into one, bringing the new headcount of the Hoegaarden facility to over 300 full time employees.